Physical Description
Pale yellow to beige powder
Residue on Ignition
≤ 4.0%
Specification Version
1.1
Not classified as a hazardous substance or mixture
If you are publishing research using GA1723 please contact us to contribute to our list of citations.
A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model
Jann-Tay Wang, Chia-Jui Yang, Jia-Ling Yang, Shu-Wen Lin, Yu-Chung Chuang, Wang-Huei Sheng, Yee-Chun Chen, Shan-Chwen Chang
Microbiology Spectrum, e02551-22, 10(5) (2022)
A high daptomycin dose has been suggested for treating vancomycin-resistant
Enterococcus faecium (VREf) infections. However, even a 12 mg/kg daptomycin dose might
be insufficient for treating VREf with high daptomycin minimum inhibitory concentrations
(MICs). Additionally, animal pharmacodynamic…
read more
mcr-1 colistin resistance gene sharing between Escherichia coli from cohabiting dogs and humans, Lisbon, Portugal, 2018 to 2020
Menezes Juliana, Moreira da Silva Joana, Frosini Sian-Marie, Loeffler Anette, Weese Scott, Perreten Vincent, Schwarz Stefan, Telo da Gama Luís, Amaral Andreia Jesus and Pomba Constança
Eurosurveillance, , 27(44) (2022)
The emergence of colistin resistance is a One Health antimicrobial resistance challenge worldwide. The close contact between companion animals and humans creates opportunities for transmission and dissemination of colistin-resistant bacteria.
To detect potential animal reservoirs of colistin-resis…
read more
Australia
Austria
Belgium
Canada
Czech Republic
Denmark
France
Germany
Greece
Hungary
Ireland
Israel
Italy
Japan
Korea South
Netherlands
New Zealand
Norway
Poland
Portugal
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
United States
Vietnam
